Molecular imaging of multiple sclerosis: from the clinical demand to novel radiotracers.
Matteo BaucknehtSelene CapitanioStefano RaffaLuca RoccatagliataMatteo PardiniCaterina LapucciCecilia MariniGianmario SambucetiMatilde InglesePaolo GalloDiego CecchinFlavio NobiliSilvia MorbelliPublished in: EJNMMI radiopharmacy and chemistry (2019)
While several preclinical and fewer clinical studies have shown results, full-scale clinical development programs are needed to translate molecular imaging technologies into a clinical reality that could ideally fit into current precision medicine perspectives.